Bolt Biotherapeutics

-$0.14 (-1.08%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BOLT and other ETFs, options, and stocks.

About BOLT

Bolt Biotherapeutics, Inc. is a clinical-stage immuno-oncology company developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company was founded by Edgar G.

CEO
Randall C. Schatzman
Employees
65
Headquarters
Redwood City, California
Founded
2015

BOLT Key Statistics

Market Cap
476.55M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
85.03K
High Today
$13.06
Low Today
$12.61
Open Price
$13.00
Volume
83.22K
52 Week High
$43.07
52 Week Low
$10.75

BOLT Earnings

-$14.58
-$9.72
-$4.86
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 11, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure